The overall aim of Progress is to support and accelerate the deployment of Industrial biotechnology (IB) in the EU industry by identifying high-value opportunities for IB and proposing actions to address them successfully. In order to achieve this overall aim the following specific key objectives are formulated for Progress:
Provide a comprehensive and dependable information base which allows for plausible estimations on the future of IB in the EU in the short and medium-term. In order to explore the relationship and dynamics between key factors for the future of IB as well as to explore future paths and the impact of changing policies and framework conditions a modelling and simulation approach will be conducted.
Elaborate a future scenario for IB in Europe containing most promising value chains, related R&D&I needs, key actors, applications, estimation of market and industrial growth, and necessitated policies for IB in Europe. This will take into account technological developments, key actors, business models, industry developments, societal goals, social acceptance, demands and framework conditions.
Engage with the different communities and support the cross-cutting connection of research groups, industrial actors, policy makers and society and to foster a common vision about the future of IB in Europe based on the aimed project results (see Objective 1 and 2) and to enable strategic partnerships along the value chains and across the Member States.
Provide strategic advice for research, industry and policy regarding potential issues/topics for collaboration, future policy programmes, the required technological infrastructure, capabilities, and economic structures. A main focus will be to identify opportunities for collaboration between EU Member States and proposed actions to increase awareness and incentives for those collaborations.